Australia’s primary care system is under sustained pressure. GP shortages persist across metropolitan and rural areas, chronic disease continues to rise, and access gaps remain across aged care, disability and community settings.
In response, the Nursing and Midwifery Board of Australia has approved a new prescribing pathway for Registered Nurses, with the first cohort expected to begin prescribing in mid-2026.
The reform expands scope, but does not create independent nurse prescribers. Registered Nurses must complete approved postgraduate education and prescribe within a formal collaborative arrangement with a doctor or nurse practitioner.
For healthcare leaders, the question is not whether nurses should prescribe. It is how this model will work in practice, and what it means for governance, workflow and business sustainability.
What has changed
Under the new pathway, eligible Registered Nurses will be authorised to prescribe certain medicines within defined clinical parameters.
Key elements of the model include:
- Completion of approved postgraduate education
- Prescribing limited to an endorsed scope of practice
- A formal collaborative arrangement with a medical practitioner or nurse practitioner
- Compliance with professional standards and regulatory oversight
This is structured, conditional prescribing. It is not autonomous or unsupervised practice.
Annie Butler, Federal Secretary of the Australian Nursing and Midwifery Federation, said the pathway was introduced in response to growing system demand.
“The RN prescribing pathway was designed to respond to workforce shortages and to improve timely access to care, due to increasing demand across primary and aged care. Australia is experiencing sustained pressure from an ageing population, rising rates of chronic disease, and reduced access to general practitioner (GP) appointments in many regions.”
Why the reform now
The broader system context matters.
Australia faces workforce shortages across general practice and aged care. An ageing population is driving more complex, long-term health needs. Rural and remote communities continue to experience limited access to timely medical care.
Expanding Registered Nurse scope is positioned as one lever to improve responsiveness without compromising safety.
“In residential aged care particularly, delays in medication charting and renewals have contributed to avoidable hospital transfers and after-hours prescribing burdens. The pathway aims to formalise and regulate medication management activities already performed by experienced Registered Nurses, improving efficiency and enhancing continuity of care across high demand settings,” Butler said.
Expanding scope does not remove system pressure. It redistributes it.
For practice owners and healthcare executives, the operational design of this reform will determine whether it relieves strain or introduces new complexity.

How the model will work day to day
In practical terms, Registered Nurse prescribing will sit within team-based care models.
The requirement for a formal collaborative arrangement is central. Prescribing decisions must occur within a defined professional relationship with a doctor or nurse practitioner. That implies:
- Agreed protocols and clinical boundaries
- Clear documentation processes
- Defined escalation pathways
- Shared governance responsibilities
For practices, this means policy updates, supervision structures and documentation workflows must be reviewed well before mid-2026.
Indemnity coverage will also require attention. Practice owners will need to confirm insurance arrangements reflect expanded scope and shared accountability.
What this means for GPs and nurse practitioners
For General Practitioners, the reform may offer relief in specific contexts. Routine medication management, repeat prescribing within established care plans and chronic disease follow-up could, in time, be distributed more effectively across the team.
However, collaborative arrangements do not eliminate oversight responsibilities. Governance remains shared. Documentation standards must be clear. Clinical leadership must be explicit.
For nurse practitioners, the model creates another layer within advanced practice hierarchies. Clear delineation between Registered Nurse prescribing scope and nurse practitioner autonomy will be essential to avoid confusion.
This reform does not flatten roles. If anything, it makes role clarity critical.
Commercial and operational implications
From a business perspective, Registered Nurse prescribing could:
- Improve appointment throughput
- Reduce wait times for routine medication management
- Enhance continuity of care in aged care and community settings
- Strengthen multidisciplinary team models
But it may also introduce:
- Additional training costs
- Governance and compliance workload
- Documentation complexity
- Potential indemnity premium adjustments
The financial impact will vary by setting.
Rural practices may see access benefits sooner. Large multidisciplinary clinics may integrate prescribing into established team-based models more easily. Smaller practices will need to weigh training investment against projected demand.
The reform is unlikely to transform revenue streams overnight. It is more likely to incrementally reshape workflow design and service allocation.
“From an ANMF perspective, consideration should be given to how the reform may affect workforce utilisation, supervision structures, clinical governance, and team-based models of care,” Butler said.
Governance is the real work
Scope expansion in healthcare is rarely just about access. It is about accountability.
Practice leaders should begin preparing now by:
- Reviewing collaborative agreement templates
- Clarifying supervision and escalation protocols
- Confirming indemnity arrangements
- Mapping prescribing workflow within electronic medical record systems
- Identifying suitable Registered Nurses for postgraduate training pathways
Waiting until mid-2026 will compress implementation timelines unnecessarily.
Leadership takeaway: design before demand
Registered Nurse prescribing is not a sudden disruption. It is a structured reform with a defined education pathway and collaborative guardrails.
Whether it relieves pressure or creates friction will depend on preparation.
Practices that treat this as a governance exercise, not just a workforce announcement, will be better positioned to integrate prescribing safely and sustainably.
Healthcare reform rarely removes complexity. It reallocates it. Practices that plan early will feel the difference first.
Sources:
New standard to enable registered nurse prescribing
https://www.ahpra.gov.au/News/2025-05-30-RNs-poised-to-prescribe-in-major-leap-for-healthcare-access-and-delivery.aspx
Nurse prescribing in 2026: what practice leaders should prepare for now
Julia Lewis
Share this article
Key takeaways
Australia’s primary care system is under sustained pressure. GP shortages persist across metropolitan and rural areas, chronic disease continues to rise, and access gaps remain across aged care, disability and community settings.
In response, the Nursing and Midwifery Board of Australia has approved a new prescribing pathway for Registered Nurses, with the first cohort expected to begin prescribing in mid-2026.
The reform expands scope, but does not create independent nurse prescribers. Registered Nurses must complete approved postgraduate education and prescribe within a formal collaborative arrangement with a doctor or nurse practitioner.
For healthcare leaders, the question is not whether nurses should prescribe. It is how this model will work in practice, and what it means for governance, workflow and business sustainability.
What has changed
Under the new pathway, eligible Registered Nurses will be authorised to prescribe certain medicines within defined clinical parameters.
Key elements of the model include:
This is structured, conditional prescribing. It is not autonomous or unsupervised practice.
Annie Butler, Federal Secretary of the Australian Nursing and Midwifery Federation, said the pathway was introduced in response to growing system demand.
“The RN prescribing pathway was designed to respond to workforce shortages and to improve timely access to care, due to increasing demand across primary and aged care. Australia is experiencing sustained pressure from an ageing population, rising rates of chronic disease, and reduced access to general practitioner (GP) appointments in many regions.”
Why the reform now
The broader system context matters.
Australia faces workforce shortages across general practice and aged care. An ageing population is driving more complex, long-term health needs. Rural and remote communities continue to experience limited access to timely medical care.
Expanding Registered Nurse scope is positioned as one lever to improve responsiveness without compromising safety.
Expanding scope does not remove system pressure. It redistributes it.
For practice owners and healthcare executives, the operational design of this reform will determine whether it relieves strain or introduces new complexity.
How the model will work day to day
In practical terms, Registered Nurse prescribing will sit within team-based care models.
The requirement for a formal collaborative arrangement is central. Prescribing decisions must occur within a defined professional relationship with a doctor or nurse practitioner. That implies:
For practices, this means policy updates, supervision structures and documentation workflows must be reviewed well before mid-2026.
Indemnity coverage will also require attention. Practice owners will need to confirm insurance arrangements reflect expanded scope and shared accountability.
What this means for GPs and nurse practitioners
For General Practitioners, the reform may offer relief in specific contexts. Routine medication management, repeat prescribing within established care plans and chronic disease follow-up could, in time, be distributed more effectively across the team.
However, collaborative arrangements do not eliminate oversight responsibilities. Governance remains shared. Documentation standards must be clear. Clinical leadership must be explicit.
For nurse practitioners, the model creates another layer within advanced practice hierarchies. Clear delineation between Registered Nurse prescribing scope and nurse practitioner autonomy will be essential to avoid confusion.
This reform does not flatten roles. If anything, it makes role clarity critical.
Commercial and operational implications
From a business perspective, Registered Nurse prescribing could:
But it may also introduce:
The financial impact will vary by setting.
Rural practices may see access benefits sooner. Large multidisciplinary clinics may integrate prescribing into established team-based models more easily. Smaller practices will need to weigh training investment against projected demand.
The reform is unlikely to transform revenue streams overnight. It is more likely to incrementally reshape workflow design and service allocation.
“From an ANMF perspective, consideration should be given to how the reform may affect workforce utilisation, supervision structures, clinical governance, and team-based models of care,” Butler said.
Governance is the real work
Scope expansion in healthcare is rarely just about access. It is about accountability.
Practice leaders should begin preparing now by:
Waiting until mid-2026 will compress implementation timelines unnecessarily.
Leadership takeaway: design before demand
Registered Nurse prescribing is not a sudden disruption. It is a structured reform with a defined education pathway and collaborative guardrails.
Whether it relieves pressure or creates friction will depend on preparation.
Practices that treat this as a governance exercise, not just a workforce announcement, will be better positioned to integrate prescribing safely and sustainably.
Healthcare reform rarely removes complexity. It reallocates it. Practices that plan early will feel the difference first.
Sources:
New standard to enable registered nurse prescribing
https://www.ahpra.gov.au/News/2025-05-30-RNs-poised-to-prescribe-in-major-leap-for-healthcare-access-and-delivery.aspx
Julia Lewis
Share this article
Latest news
Clinical & consumer healthMarket intelligence & industry trendsPolicy reformsPolicy, compliance & governance
Building pressure: what’s straining Australia’s hospitals and how to build resilience
Game changersInnovation & technology
Why Yupin Robson is rebuilding specialist care from the inside out
Innovation & technology
CareRight launches Care Encounter Manager to streamline multidisciplinary care
Opinion & commentary
Healthcare doesn’t have an innovation problem. It has an execution problem.
Business growth & marketingClinical & consumer healthGame changers
The power of connection in healthcare: Veri talks business growth with Sharon Armstrong
Join our exclusive community!
You might also like
Building pressure: what’s straining Australia’s hospitals and how to build resilience
The 2026 federal budget: What healthcare business leaders should be watching
Thriving Kids explained: what early childhood providers should prepare for now
Peak nursing body calls for urgent federal investment ahead of 2026–27 budget
Inside MSIA’s voluntary AI code – and what it signals for healthcare decision-makers